Skip to main content

Table 2 Crude and adjusted odds ratios and 95% confidence intervals for associations between clinical outcomes and CAR

From: Effect of disease duration on the association between C-reactive protein-albumin ratio and endoscopic activity in ulcerative colitis

Variable

Prevalence (%)

Crude OR (95%CI)

Adjusted OR (95%CI)

Clinical remission

   

 Low CAR

58/93 (62.4)

1.00

1.00

 Moderate CAR

56/89 (62.9)

1.02 (0.56–1.87)

1.15 (0.59–2.25)

 High CAR

44/91 (48.4)

0.57 (0.31–1.01)

0.58 (0.30–1.15)

p for trend

  

0.12

Mucosal healing (MES < 1)

   

 Low CAR

27/93 (29.0)

1.00

1.00

 Moderate CAR

29/89 (32.6)

1.18 (0.63–2.23)

1.35 (0.69–2.68)

 High CAR

15/91 (16.5)

0.48 (0.23–0.97)

0.49 (0.22–1.07)

p for trend

  

0.10

Moderate to severe activity (MES 2 or 3)

   

 Low CAR

27/93 (29.0)

1.00

1.00

 Moderate CAR

29/89 (32.6)

1.18 (0.63–2.23)

1.12 (0.57–2.20)

 High CAR

45/91 (49.5)

2.39 (1.31–4.43)

2.18 (1.11–4.35)

p for trend

  

0.023

  1. Odds ratios were adjusted for age, sex, BMI, use of prednisolone, use of TNF-α monoclonal antibody, C-reactive protein, disease extent and disease duration. OR, odds ratio; CI, confidence interval; CAR, C-reactive protein to albumin ratio; MES, Mayo Endoscopic Subscore